Neoadjuvant chemoradiotherapy plus sequential tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): A single-arm, bicentric, phase 2 trial

作者：Jinsong Yang, Cui Liu, Zhigang Zuo, Fengjun Cao, Zhanjie Zhang, Bian Wu, You Qin, Lu Wen, Jielin Wei, Guangqin Xiao, Shijie Xing, Yue Qu, Lei Huang, Xiaolin Wang, Buhai Wang, Kunyu Yang, Ke Jiang · 发表于：Radiotherapy and Oncology · 年份：2025 · DOI：10.1016/j.radonc.2025.110797 · 被引用次数：6 · 研究领域：Esophageal Cancer Research and Treatment、Cancer Immunotherapy and Biomarkers、Pancreatic and Hepatic Oncology Research